The Corporate Executive Committee is responsible for managing Bachem worldwide and for implementing policies and strategies as defined by the Board of Directors.
Chief Executive Officer (CEO)
Chief Financial Officer (CFO)
Alain Schaffter started his career as an auditor at PricewaterhouseCoopers. In 2010, he moved into the pharmaceutical industry and became Head Group Finance of the listed Acino Group before joining Polyphor, a Basel-based biotech company, as CFO in 2016.
In early 2018, he started to work as a consultant for several companies in the Life Science Industry, supporting them in specific projects like Reporting, IFRS conversion or IPO preparation before he became Head Special Finance Projects at Solvias AG in August 2018. There he ran and coordinated the due diligence and deal related activities for the sale of Solvias Group to two Healthcare Investors, including process optimization in the areas of Accounting, Tax and Reporting. After completion of the transaction in June 2020, Alain Schaffter assumed, in addition to his existing role, the role as Head Finance M&A but also as CFO on an ad interim basis.
He served also as a Member of Group Executive Committees and held various mandates as Chairman of the Board of Trustees and as a member of the Board of Directors, of the Management Board and of the Audit Committee at subsidiaries worldwide.
Alain Schaffter holds a degree as a Swiss certified public accountant as well as a Federal certificate of higher vocational education and training for fiduciaries.
Chief Technology Officer (CTO)
Guenther Loidl joined Bachem in 2000. He held several functions in Research and Development (R&D) and Active Pharmaceutical Ingredient Manufacturing and became Vice President R&D in 2012. Since 2015, he is CTO of the Bachem Group and a member of the Corporate Executive Committee.
He studied chemistry in Regensburg (Germany) and Leeds (UK) and obtained his doctorate under the supervision of Prof. Dr. Luis Moroder at the Max Planck Institute of Biochemistry in Martinsried (Germany).
Chief Marketing Officer (CMO)
Anne-Kathrin Stoller joined Bachem AG in Bubendorf in 2006 and headed the Business Development Unit from 2008 to 2010. Subsequently, she was responsible for the Business Development & Sales Department, first locally and finally for the entire region Europe. Serving as Vice President and Department Head she was also a member of the local management team in Bubendorf. Since January 1, 2018, she is CMO of the Bachem Group and member of the Corporate Executive Committee.
Anne-Kathrin Stoller studied chemistry in Hannover (Germany) and Cambridge (UK). After obtaining her doctorate under the supervision of Prof. Dr. Bernd Giese at the University of Basel (Switzerland), she started her career in the sales team of Exxonmobil Chemical.
Chief Operating Officer (COO)
Roland Schürmann joined Bachem Americas, Inc. in Torrance, California in 2016. He was first Vice President Manufacturing and became Site Manager Torrance in May 2017. Roland Schürmann was appointed COO of the Bachem Group and member of the Corporate Executive Committee effective July 1, 2020. After completing his education, he worked as a chemical laboratory technician at Ciba-Geigy AG and as a production chemist at F. Hoffmann-La Roche Ltd from 1984 to 1997. After holding various management positions at Siegfried AG in Zofingen, Switzerland, Roland Schürmann became Head of Chemical Production in 2004. Parallel to working, he was a senior lecturer for Chemical Technology from 1999 to 2015 at the vocational college in Aarau.
Roland Schürmann has a university of applied sciences degree in chemistry from the School of Engineering Burgdorf and is currently completing the Advanced Management Program at INSEAD Business School, Fontainebleau/Paris.
Board of Directors
The Board of Directors are responsible for defining Bachem’s corporate strategy and are elected by the company shareholders.
Click here >>
Our passionate and dedicated employees, along with our unique corporate culture are the foundation of our success.
Click here >>